论文部分内容阅读
目的分析小剂量利维爱短期给药对绝经后骨质疏松的预防效果。方法选取本院2012年4月~2014年3月收治的100例绝经后骨质疏松症患者,随机分为参照组和试验组,每组各50例。参照组患者口服碳酸钙D3片治疗,试验组患者在此基础上辅以小剂量利维爱短期给药治疗。连续用药12周,对比分析两组患者腰椎疼痛程度、L2~4腰椎骨密度的差异性。结果经过治疗后所有患者腰椎疼痛VAS评分均有所下降,L2~4腰椎骨密度均有所上升,其中试验组治疗后腰椎疼痛VAS评分明显低于参照组,L2~4腰椎骨密度明显高于参照组,t检验结果显于组间差异有统计学意义(P<0.05)。结论采用小剂量利维爱短期给药治疗绝经后骨质疏松症可明显缓解腰背疼痛症状,增加患者骨密度,值得推广。
Objective To analyze the preventive effect of short-term levofloxacin on postmenopausal osteoporosis. Methods A total of 100 patients with postmenopausal osteoporosis admitted from April 2012 to March 2014 in our hospital were randomly divided into a reference group and a test group, with 50 cases in each group. The reference group of patients treated with oral calcium carbonate D3 tablets, patients in the test group supplemented with low-dose leviotherapy on short-term basis. Continuous treatment for 12 weeks, comparative analysis of two groups of patients with lumbar pain, L2 ~ 4 lumbar spine bone mineral density differences. Results After treatment, the VAS scores of lumbar pain decreased in all patients, and the BMD of L2 ~ 4 lumbar vertebrae increased. The VAS score of lumbar pain in the experimental group was significantly lower than that of the reference group, and the lumbar spine BMD of L2 ~ 4 was significantly higher The reference group, t test showed significant differences between groups (P <0.05). Conclusion Short-term use of low-dose levi available for the treatment of postmenopausal osteoporosis can significantly relieve the symptoms of low back pain, increase the patient’s bone mineral density, it is worth promoting.